About HCW Biologics Inc. Common Stock
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
Market Cap
$0.01B
Employees
45
Listed Since
July 20, 2021
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.hcwbiologics.comPhone
954-842-2024
Headquarters
2929 N COMMERCE PKWY
MIRAMAR, FL 33025
CIK
0001828673